Replies to post #776489 on NorthWest Biotherapeutics Inc (NWBO)

[barnstormer]

Slave, thanks for your detailed input as always. But it does address an ongoing question I've had that I'd appreciate your input on, namely when does a variation not part of the initial MAA need to be made public. In particular, if it expands the MAA to include treatment of other forms of cancer and/or inclusion of the EDEN system, is the addition not required to be made public since it may have a significant impact on the share price? Not talking about providing anything that impacts MHRA process, just an announcement by the company the variation has been filed.

[jesster64]

Thank You again slave1 for the thorough explanation . It took me a while to digest and I still need to go over it a few times. However, I recently contacted friends and family and said the time is near. I'm getting the usual stink eye since I've said this before, but your answers make complete sense and I am confident once again on nearby approval. One further question for today, does the july 24th or any upcoming UK legislation have any bearing on approval timeline, in your opinion? Or is everything most likely complete and waiting smpc to be written?

[JTORENCE]

Slave1 After painstakingly reading your A1 post ,I have slipped my MHA approval to mid 2026.Just a wee bit to many hurdles for NWBO to get over this year. Imo

[dennisdave]

you really should stop your absurd, wild speculation based on absolutely nothing you are not doing any of these folks a favour. Its very easy to gain traction here to just tell people what they want to hear and good for you for getting all these thumbs up because of it, but most of what you post is based on fantasy.

There are/have been posters claiming NWBO will be worth $ 100 per share after MHRA, same fantasy,y same thumbs u,p same hopium.

[barnstormer]

Slave, thanks for the input as always. If Flaskwork/EDEN had been added as an amendment after the original MAA submission given the potential impact the knowledge might have had on share price, shouldn't the company have made the change public? Just notification of the addition would not seem at odds with MHRA requirements if it was limited to simply noting the change. Thanks in advance.